915-OMEPRAZOLE DELAYED RELEASE TABLETS 20 mg

Perrigo Company

Revision date : 2012-11-16

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

63-42-3

Name of the chemical

Lactose C12H22O11

Concentration

N/A

EC/CAS

14807-96-6

Name of the chemical

Talc

Concentration

N/A

EC/CAS

77-93-0

Name of the chemical

citric acid, triethyl ester

Concentration

N/A

EC/CAS

141-43-5

Name of the chemical

2-aminoethanol

Concentration

N/A

EC/CAS

8015-86-9

Name of the chemical

carnauba wax

Concentration

N/A

General Information

Revision date

2012-11-16

Product name

915-OMEPRAZOLE DELAYED RELEASE TABLETS 20 mg

supplier name

Perrigo Company

Icons in SDS

M019

Company Information

company name

Perrigo Company

e-mail address of the competent person responsible for the Safety Data Sheet

blackey@perrigo.com

Section 2

SECTION 2: Hazards identification

OSHA Emergency Overview May cause eye irritation May be harmful if swallowed in amounts above the therapeutic dose Consumers: Refer to the package insert for consumer-specific information about the directional use and effects of this product Only information about the ingredients that are expected to contribute to the potential health effects of the product are included in this MSDS Do not use if printed seal under cap is broken or missing Appearance White Physical State Solid. Odor No information available OSHA Regulatory Status Over-the counter drugs in their final form as sold to the consumer are considered exempt under the criteria of the Federal OSHA Communication Standard 29CFR1910.1200. However, if exposure may occur in the industrial setting, outside of personal use, the occupational exposure limits may be exceeded and may be considered hazardous.

Principle Routes of Exposure

Skin contact. Ingestion. Do not take more than directed. See dosing chart for more information. Acute Toxicity Eyes May cause irritation Skin No known effect based on information supplied. Inhalation No known effect based on information supplied Ingestion No known effect when taken as indicated. Ingestion at levels above recommended values may be harmful. See package insert for further information.

Potential chronic health

Titanium dioxide has been classified by the International Agency for Research on Cancer (IARC) as possibly carcinogenic to humans (Group 2B) by inhalation This product contains titanium dioxide in a non-respirable form. Inhalation of titanium dioxide is unlikely to occur from exposure to this product

Medical Conditions Generally Aggravated by Exposure

Gastrointestinal tract. If pregnant or breast feeding ask a health professional before use. 20 mg _____________________________________________________________________________________________

Interactions with other chemicals

Ask a doctor or pharmacist before use if you are taking: Warfarin, clopidogrel or cilostazol (blood-thinning medicines) Prescription anti-fungal or anti-yeast medicines. Diazepam (anxiety medicine) Digoxin (heart medicine) Tacrolimus (immune system medicine) Prescription antiretrovirals (medicine for HIV infection)

Environmental hazards

See Section 12 for additional Ecological information.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.